drug · small molecule
patient view →rimegepant sulfate ODT
Marketedupdated 2mo agoby $PFE PFIZER INC🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval, with an approval for migraine disorder.
targets
Calcitonin gene-related peptide type 1 receptor
all catalysts(10)
approval · 10
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that